Pure Global AI
NCT06098170Recruiting

Acceptance and Commitment Therapy for Chronic Pain in SCI: Development and Testing of an eHealth Program

University of MichiganClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Spinal Cord Injuries
Drug/Device/Intervention
Unguided use of the My SCI Toolkit program
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Michigan
Location
Ann Arbor, United States of America
Timeline & enrollment
Phase
N/A
Start date
Nov 15, 2023
End date
Oct 01, 2025
Enrollment
60 participants
Primary outcome

Percent of participants in each arm that dropped out of the study,Number of days/week that My SCI Toolkit was accessed,Number of minutes/week spent on the My SCI Toolkit website,Participant Satisfaction Evaluation,Patient Global Impression of Change (PGIC),Change in SCI-QOL Pain Interference Short Form

Summary

This study will test the newly-developed My spinal cord injury (SCI) Toolkit program in two
 formats - unguided use of the program and use supported by a coach. These two active
 treatment formats will be compared to treatment as usual (waitlist control) in adults with
 chronic pain and SCI.
 
 Hypotheses include:
 
 - Treatment adherence, participant satisfaction, and perception of positive change will be
 high and drop-out rates low for both treatments but will be better in the coached
 compared to the unguided arm
 
 - In terms of pre- to post-treatment changes in pain interference, coached My SCI Toolkit
 program will be superior to treatment as usual

ICD-10 classifications
Sequelae of injury of spinal cordOther and unspecified injuries of thoracic spinal cordOther and unspecified injuries of cervical spinal cordOther injury of lumbar spinal cordInjury of spinal cord, level unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06098170
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06098170 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Michigan and is currently Recruiting. The study focuses on Spinal Cord Injuries. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.